PROCEPT BioRobotics prices Nasdaq IPO
PROCEPT BioRobotics priced its upsized initial public offering and expected its shares to begin trading on Nasdaq under the PRCT ticker.
Verified eventPROCEPT BioRoboticsSep 15, 2021
Evidence notes
- PROCEPT expected its common stock to begin trading on the Nasdaq Global Market on September 15, 2021.
- The IPO was priced at $25.00 per share.
- The company offered all shares in the upsized offering.
Company overview
PROCEPT BioRobotics develops surgical robotic systems for Aquablation therapy, including image-guided robotic waterjet treatment for benign prostatic hyperplasia.